Rasuvo

Active Ingredient(s): Methotrexate
FDA Approved: * July 10, 2014
Pharm Company: * MEDAC PHARMA INC
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Rasuvo Overview

Methotrexate (MTX), formerly known as amethopterin, is a chemotherapy agent and immune system suppressant.[1] It is used to treat cancer, autoimmune diseases, ectopic pregnancy, and for medical abortions.[1] Types of cancers it is used for include breast cancer, leukemia, lung cancer, lymphoma, and osteosarcoma.[1] Types of autoimmune diseases it is used for include psoriasis, rheumatoid arthritis, and Crohn's disease.[1] It can ...

Read more Rasuvo Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Methotrexate

Recent Rasuvo Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Methotrexate
  • Injection: 10 Mg/0.4 Ml, 15 Mg/0.4 Ml, 20 Mg/0.4 Ml And 25mg/0.4 Ml, 1000mg, 100mg/4ml (25mg/ml), 100mg/vial, 10mg/0.20ml, 12.5mg/0.25ml, 15mg/0.30ml, 17.5mg/0.35ml, 1g, 1gm/40ml (25 mg/ml), 1gm/40ml (25mg/ml), 1gm/vial, 2.5gm/100ml (25 mg/ml), 2.5gm/100ml (25mg/ml), 2.5mg/ml, 200mg/8ml (25mg/ml), 20mg, 20mg/0.4ml, 20mg/2ml (10 mg/ml), 20mg/2ml (10mg/ml), 20mg/vial, 22.5mg/0.45ml, 250mg/10ml (25mg/ml), 25mg/0.50ml, 25mg/ml, 27.5mg/0.55ml, 30mg/0.60ml, 500mg/20ml (25 mg/ml), 500mg/20ml (25mg/ml), 50mg/2ml (25 mg/ml), 50mg/2ml (25mg/ml), 50mg/vial, 7.5mg/0.15ml
  • Powder: 100%
  • Solution: 10mg/0.20ml, 10mg/0.20ml (10mg/0.20ml), 10mg/0.4ml, 10mg/0.4ml (10mg/0.4ml), 12.5mg/0.25ml, 12.5mg/0.25ml (12.5mg/0.25ml), 12.5mg/0.4ml (12.5mg/0.4ml), 15mg/0.30ml, 15mg/0.30ml (15mg/0.30ml), 15mg/0.4ml, 15mg/0.4ml (15mg/0.4ml), 15mg/0.6ml (15mg/0.6ml), 17.5mg/0.35ml, 17.5mg/0.35ml (17.5mg/0.35ml), 17.5mg/0.4ml (17.5mg/0.4ml), 17.5mg/0.7ml (17.5mg/0.7ml), 2.5mg/ml, 20mg/0.4ml, 20mg/0.4ml (20mg/0.4ml), 20mg/0.8ml (20mg/0.8ml), 22.5mg/0.45ml, 22.5mg/0.45ml (22.5mg/0.45ml), 22.5mg/0.4ml (22.5mg/0.4ml), 22.5mg/0.9ml (22.5mg/0.9ml), 25mg/0.4ml, 25mg/0.4ml (25mg/0.4ml), 25mg/0.5ml, 25mg/0.5ml (25mg/0.5ml), 25mg/ml (25mg/ml), 27.5mg/0.55ml, 27.5mg/0.55ml (27.5mg/0.55ml), 2mg/ml, 30mg/0.6ml, 30mg/0.6ml (30mg/0.6ml), 7.5mg/0.15ml, 7.5mg/0.15ml (7.5mg/0.15ml), 7.5mg/0.4ml, 7.5mg/0.4ml (7.5mg/0.4ml)
  • Tablet: 10mg, 15mg, 2.5mg, 5mg, 7.5mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Rasuvo: (10 results)

Sorted by National Drug Code
  • 59137-505 Rasuvo 7.5 mg/.15ml Subcutaneous Injection, Solution by Medac Pharma, Inc
  • 59137-510 Rasuvo 10 mg/.2ml Subcutaneous Injection, Solution by Medac Pharma, Inc
  • 59137-515 Rasuvo 12.5 mg/.25ml Subcutaneous Injection, Solution by Medac Pharma, Inc
  • 59137-520 Rasuvo 15 mg/.3ml Subcutaneous Injection, Solution by Medac Pharma, Inc
  • 59137-525 Rasuvo 17.5 mg/.35ml Subcutaneous Injection, Solution by Medac Pharma, Inc
  • 59137-530 Rasuvo 20 mg/.4ml Subcutaneous Injection, Solution by Medac Pharma, Inc
  • 59137-535 Rasuvo 22.5 mg/.45ml Subcutaneous Injection, Solution by Medac Pharma, Inc
  • 59137-540 Rasuvo 25 mg/.5ml Subcutaneous Injection, Solution by Medac Pharma, Inc
  • 59137-545 Rasuvo 27.5 mg/.55ml Subcutaneous Injection, Solution by Medac Pharma, Inc
  • 59137-550 Rasuvo 30 mg/.6ml Subcutaneous Injection, Solution by Medac Pharma, Inc

Other drugs which contain Methotrexate or a similar ingredient: (8 results)

Related Rasuvo Topics:

Rasuvostatin
what is rasuvastatin...




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 October 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA